Precision Medicine
In session V of iwNHL 2018, Anas Younes, MD, Franck Morschhauser, MD, PhD, Thomas Witzig, MD, and Davide Rossi, MD discuss the introduction of new precision medicines for lymphomas and other treatment methods.
Presentations
Memorial Sloan Kettering Cancer Center, New York City, NY
Anas Younes, MD, from Memorial Sloan Kettering Cancer Center, New York City, NY, gives us a talk on precision medicine trials in lymphoma.
Centre Hospitalier Régional Universitaire de Lille, Lille, France
Franck Morschhauser, MD, PhD, from Centre Hospitalier Régional Universitaire de Lille, Lille, France, speaks on precision medicine in follicular lymphoma.
Mayo Clinic, Rochester, MI
Thomas Witzig, MD, from Mayo Clinic, Rochester, MI, talks about applying a precision medicine approach across different histological subtypes in lymphoma.
Institute of Oncology Research, Bellinzona, Switzerland
Davide Rossi, MD, from Institute of Oncology Research, Bellinzona, Switzerland, speaks on the role of circulating tumor DNA in guiding lymphoma treatments.
